马来西亚食欲抑制剂诱发的心肌梗死 - Suppr

Suppr

超能文献

Myocardial infarction induced by appetite suppressants in Malaysia.

作者信息

Azarisman Shah M, Magdi Yahya A, Noorfaizan Saidin, Oteh Maskon

出版信息

N Engl J Med. 2007 Nov 1;357(18):1873-4. doi: 10.1056/NEJMc070990.

DOI:10.1056/NEJMc070990

PMID:17978302

Abstract

摘要

相似文献

Myocardial infarction induced by appetite suppressants in Malaysia.

N Engl J Med. 2007 Nov 1;357(18):1873-4. doi: 10.1056/NEJMc070990.

Appetite suppressants in pregnancy.

Neuro Endocrinol Lett. 2012;33 Suppl 3:179-82.

Myocardial infarction associated with sibutramine use: case report and discussion.

Mil Med. 2010 Aug;175(8):622-4. doi: 10.7205/milmed-d-10-00011.

Sibutramine--another flawed diet pill.

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

Studies confirm link between fen-phen and heart-valve disease.

Harv Heart Lett. 1998 Dec;9(4):4-6.

Obesity.

Clin Evid. 2003 Dec(10):676-89.

Sibutramine-induced acute myocardial infarction in a young lady.

Clin Toxicol (Phila). 2008 Nov;46(9):877-9. doi: 10.1080/15563650802136258.

Appetite suppressants and valvular heart disease.

N Engl J Med. 1998 Sep 10;339(11):765-6. doi: 10.1056/NEJM199809103391109.

[32-year-old patient with acute myocardial infarction possibly induced by the appetite suppressant sibutramine].

Dtsch Med Wochenschr. 2010 May;135(19):965-8. doi: 10.1055/s-0030-1253684. Epub 2010 May 5.

Phentermine cardiovascular safety.

Am J Emerg Med. 2009 Oct;27(8):1010-3. doi: 10.1016/j.ajem.2009.07.014.

引用本文的文献

Inferior Wall STEMI in a Young Patient-A Sequela of Phentermine and Smoking.

J Community Hosp Intern Med Perspect. 2025 May 5;15(3):90-93. doi: 10.55729/2000-9666.1483. eCollection 2025.

Cardiogenic shock in a 28-year-old woman associated with sibutramine use.

Int J Legal Med. 2024 May;138(3):833-838. doi: 10.1007/s00414-023-03147-2. Epub 2024 Jan 10.

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries.

Cureus. 2022 Dec 2;14(12):e32138. doi: 10.7759/cureus.32138. eCollection 2022 Dec.

Sibutramine as a Cause of Sudden Cardiac Death.

Case Rep Cardiol. 2021 Feb 6;2021:8896932. doi: 10.1155/2021/8896932. eCollection 2021.

Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity.

Obesity (Silver Spring). 2019 Feb;27(2):190-204. doi: 10.1002/oby.22385.

Vasospastic myocardial infarction caused by a slimming agent-do not forget non-prescription drugs.

Oxf Med Case Reports. 2017 Apr 3;2017(4):omx008. doi: 10.1093/omcr/omx008. eCollection 2017 Apr.

Myocardial infarction caused by pharmacological substances - case description and literature review.

Postepy Kardiol Interwencyjnej. 2013;9(3):250-5. doi: 10.5114/pwki.2013.37504. Epub 2013 Sep 16.

Ventricular fibrillation coinciding with phentermine initiation.

BMJ Case Rep. 2012 Oct 12;2012:bcr2012006410. doi: 10.1136/bcr-2012-006410.

Sibutramine on cardiovascular outcome.

Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S114-9. doi: 10.2337/dc11-s205.

Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected.

Br J Clin Pharmacol. 2011 Feb;71(2):250-3. doi: 10.1111/j.1365-2125.2010.03822.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Myocardial infarction induced by appetite suppressants in Malaysia.

N Engl J Med. 2007 Nov 1;357(18):1873-4. doi: 10.1056/NEJMc070990.

Appetite suppressants in pregnancy.

Neuro Endocrinol Lett. 2012;33 Suppl 3:179-82.

Myocardial infarction associated with sibutramine use: case report and discussion.

Mil Med. 2010 Aug;175(8):622-4. doi: 10.7205/milmed-d-10-00011.

Sibutramine--another flawed diet pill.

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

Studies confirm link between fen-phen and heart-valve disease.

Harv Heart Lett. 1998 Dec;9(4):4-6.

Obesity.

Clin Evid. 2003 Dec(10):676-89.

Sibutramine-induced acute myocardial infarction in a young lady.

Clin Toxicol (Phila). 2008 Nov;46(9):877-9. doi: 10.1080/15563650802136258.

Appetite suppressants and valvular heart disease.

N Engl J Med. 1998 Sep 10;339(11):765-6. doi: 10.1056/NEJM199809103391109.

[32-year-old patient with acute myocardial infarction possibly induced by the appetite suppressant sibutramine].

Dtsch Med Wochenschr. 2010 May;135(19):965-8. doi: 10.1055/s-0030-1253684. Epub 2010 May 5.

Phentermine cardiovascular safety.

Am J Emerg Med. 2009 Oct;27(8):1010-3. doi: 10.1016/j.ajem.2009.07.014.

引用本文的文献

Inferior Wall STEMI in a Young Patient-A Sequela of Phentermine and Smoking.

J Community Hosp Intern Med Perspect. 2025 May 5;15(3):90-93. doi: 10.55729/2000-9666.1483. eCollection 2025.

Cardiogenic shock in a 28-year-old woman associated with sibutramine use.

Int J Legal Med. 2024 May;138(3):833-838. doi: 10.1007/s00414-023-03147-2. Epub 2024 Jan 10.

Positive Regadenoson Stress Test in a Patient on Phentermine With Normal Coronaries.

Cureus. 2022 Dec 2;14(12):e32138. doi: 10.7759/cureus.32138. eCollection 2022 Dec.

Sibutramine as a Cause of Sudden Cardiac Death.

Case Rep Cardiol. 2021 Feb 6;2021:8896932. doi: 10.1155/2021/8896932. eCollection 2021.

Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity.

Obesity (Silver Spring). 2019 Feb;27(2):190-204. doi: 10.1002/oby.22385.

Vasospastic myocardial infarction caused by a slimming agent-do not forget non-prescription drugs.

Oxf Med Case Reports. 2017 Apr 3;2017(4):omx008. doi: 10.1093/omcr/omx008. eCollection 2017 Apr.

Myocardial infarction caused by pharmacological substances - case description and literature review.

Postepy Kardiol Interwencyjnej. 2013;9(3):250-5. doi: 10.5114/pwki.2013.37504. Epub 2013 Sep 16.

Ventricular fibrillation coinciding with phentermine initiation.

BMJ Case Rep. 2012 Oct 12;2012:bcr2012006410. doi: 10.1136/bcr-2012-006410.

Sibutramine on cardiovascular outcome.

Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S114-9. doi: 10.2337/dc11-s205.

Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected.

Br J Clin Pharmacol. 2011 Feb;71(2):250-3. doi: 10.1111/j.1365-2125.2010.03822.x.